![]() ![]() According to independent assessment, about 98% of the media sector is held by three conglomerates. Since the trend of consolidation is and has historically been upward, fewer and fewer individuals or organizations control increasing shares of the mass media in our country. ![]() Media ownership in Australia is one of the most concentrated in the world ( Learn more). We don't put up a paywall – we believe in free access to information of public interest. Well, unlike many news organisations, we have no sponsors, no corporate or ideological interests. "We want to prevent glaucoma from robbing people of the ability to drive and read and recognise their loved ones, but we need your help to do this," said Professor MacGregor. We particularly encourage people aged 50 to 65 who don't have glaucoma currently but who have a close relative (parent, sibling) with the disease to sign up. "We're urging Australians who have a personal or family history of the disease to sign up to the QIMR Berghofer Genetics of Glaucoma study. More than 5,000 Australians have already volunteered to take part in the QIMR Berghofer Genetics of Glaucoma study, but the researchers are appealing for more participants. The researchers said they are hoping to collect more data to increase the accuracy of their genetic prediction tool and find even more genes linked to glaucoma risk. "If we can find people before the disease develops, we can prevent blindness in those people," said Associate Professor Gharahkhani. We can use our genetic discoveries to identify those who are at higher risk. "Glaucoma is one of the most strongly genetic of all human diseases. Lead author Associate Professor Puya Gharahkhani from QIMR Berghofer said the findings are also helping to develop a genetic test to predict a person's risk of developing glaucoma. This could rapidly advance effective treatment to finally prevent retina and optic nerve damage." "We've also identified existing drugs that could be used on those genetic targets. "Our findings are really exciting because for the first time we've discovered the set of genes that could be targeted to induce this 'neuro-protection' in the retinal cells. The dream has always been to find a way to make the retina itself stronger so it can withstand the build-up of pressure and prevent the damage that causes permanent blindness. "Existing treatments focus only on lowering eye pressure. ![]() You don't realise what's happening until you've already suffered permanent damage and loss of vision," said Professor MacGregor. ![]() You lose your peripheral vision first, and then one eye often covers for the loss of sight in the other. Lead researcher Professor Stuart MacGregor, QIMR Berghofer's Statistical Genetics Laboratory, said the discoveries could rapidly accelerate a new approach to treatment. The disease causes pressure from fluid in the eye to build up, causing damage to the retina and the optic nerve.Īround 50 per cent of all glaucoma cases are not diagnosed until permanent optic nerve damage has occurred. Glaucoma is the leading cause of irreversible blindness globally, affecting over 75 million people worldwide, including 300,000 Australians. The research has identified another 185 previously unknown genes linked to glaucoma risk, bringing the total number to 312 genes. The findings, from the largest-ever global genetic study of the degenerative eye disease, have been published in the prestigious journal Nature Genetics. The research includes genetic targets that could, for the first time, pave the way for treatments that prevent the retinal damage that causes blindness. There is no information about the overall patient rating for AUSTIN RETINA ASSOCIATES.International research led by QIMR Berghofer has found hundreds of new genes linked to a person's risk of developing glaucoma. According to the CMS website, the 2022 survey data is being finalized but they have not indicated when it will be publicly available. The most recent data for both of these datasets is calendar year 2021. The data shown below summarizes the results of the most recent annual survey of health care providers called the Consumer Assessment of Healthcare Providers and Systems or "CAHPS" as well as data used for the calculation of the Merit-Based Incentive Payment System ("MIPS"). The information below shows the best analysis currently available. Figuring this out and boiling it down to a few measures, can be difficult. When it comes to healthcare, patients want the best possible care and experience. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |